A trial to learn how saruparib works and how safe it is in the bodies of adults with advanced solid tumors
D9723C00002
Phase 1 other active
Quick answer
A trial to learn how saruparib works and how safe it is in the bodies of adults with advanced solid tumors for advanced solid malignancies is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- advanced solid malignancies
- Phase
- Phase 1
- Modality
- other
- Status
- active